CN119816588A - 鸡毒支原体活疫苗 - Google Patents

鸡毒支原体活疫苗 Download PDF

Info

Publication number
CN119816588A
CN119816588A CN202380030880.4A CN202380030880A CN119816588A CN 119816588 A CN119816588 A CN 119816588A CN 202380030880 A CN202380030880 A CN 202380030880A CN 119816588 A CN119816588 A CN 119816588A
Authority
CN
China
Prior art keywords
mycoplasma gallisepticum
strain
vaccine
birds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380030880.4A
Other languages
English (en)
Chinese (zh)
Inventor
N·M·弗格森-诺埃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc filed Critical University of Georgia Research Foundation Inc
Publication of CN119816588A publication Critical patent/CN119816588A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CN202380030880.4A 2022-04-06 2023-04-05 鸡毒支原体活疫苗 Pending CN119816588A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263327851P 2022-04-06 2022-04-06
US63/327,851 2022-04-06
US202263404226P 2022-09-07 2022-09-07
US63/404,226 2022-09-07
PCT/US2023/017527 WO2023196374A1 (en) 2022-04-06 2023-04-05 Live mycoplasma gallisepticum vaccines

Publications (1)

Publication Number Publication Date
CN119816588A true CN119816588A (zh) 2025-04-11

Family

ID=88243428

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380030880.4A Pending CN119816588A (zh) 2022-04-06 2023-04-05 鸡毒支原体活疫苗

Country Status (7)

Country Link
US (1) US20250235521A1 (https=)
EP (1) EP4504902A4 (https=)
JP (1) JP2025510684A (https=)
CN (1) CN119816588A (https=)
AU (1) AU2023249151A1 (https=)
MX (1) MX2024011270A (https=)
WO (1) WO2023196374A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117434281B (zh) * 2023-10-18 2026-01-06 上海太阳生物技术有限公司 组合物、检测试剂、检测试剂盒以及在制备检测凝血因子x活性中的应用
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用
CN117965308B (zh) * 2024-03-07 2024-09-13 佛山科学技术学院 一种鹅源鸡毒支原体及其分离、鉴定方法和应用
CN119552994B (zh) * 2025-01-17 2025-11-14 广西壮族自治区动物疫病预防控制中心(广西壮族自治区屠宰技术中心) 鉴别鸡毒支原体野毒株和疫苗株的四重荧光pcr引物探针组合、反应体系、方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens

Also Published As

Publication number Publication date
US20250235521A1 (en) 2025-07-24
WO2023196374A1 (en) 2023-10-12
EP4504902A4 (en) 2026-05-06
EP4504902A1 (en) 2025-02-12
AU2023249151A1 (en) 2024-09-19
JP2025510684A (ja) 2025-04-15
MX2024011270A (es) 2024-09-25

Similar Documents

Publication Publication Date Title
Ley et al. Mycoplasma gallisepticum infection
Kapczynski et al. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak
CN119816588A (zh) 鸡毒支原体活疫苗
Patnayak et al. Experimental and field evaluation of a live vaccine against avian pneumovirus
KR20120016282A (ko) 마이코플라스마　하이오뉴모니에의 온도 감수성 백신 균주 및 그의 용도
CN102292432B (zh) 鸡败血支原体制剂
US11814653B2 (en) Attenuated isolate of infectious bronchitis virus strain DMV1639
UA121097C2 (uk) Імуногенна композиція, що містить антигени мікоплазм
US7217420B2 (en) Mycoplasma gallisepticum formulation
CN114828883A (zh) 减毒禽类呼肠孤病毒株94826 c140和96139 c140
US20250186512A1 (en) Live mycoplasma synoviae vaccine
Khedr et al. Trials for preparation and evaluation of combined inactivated Mycoplasma gallisepticum and Synoviae vaccine in chicken and turkey.
KR20220110785A (ko) 애비박테리움 파라갈리나룸 및 조류 뇌척수염 바이러스 및 계두 바이러스에 대한 삼중 백신
Raheem et al. Continental Veterinary Journal
Kais COMBINATION OF LIVE VACCINE AND PULMOTIL-AC IN CONTROL OF MYCOPLASMA GALLISEPTICUM IN BREEDER PULLETS
HK1161289B (en) Mycoplasma gallisepticum formulation
Hafez Respiratory diseases of turkeys–part one
KR20030055314A (ko) 칠면조 비기관지염에 대한 난내 보호를 제공하기 위한방법 및 백신
MATHEWS ASSESSMENT OF IMMUNOGENIC POTENCY OF INACTIVATED VACCINE AGAINST RIEMERELLOSIS IN BREEDER DUCKS
MXPA06011928A (es) Vacuna inactivada acuosa para la prevencion de influenza aviar.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination